Cabaletta Bio(CABA)
PHILADELPHIA, PA
BiotechnologyFocus: Chimeric Auto Antibody Receptors
Cabaletta Bio is a life sciences company focused on Chimeric Auto Antibody Receptors.
Oncology
Funding Stage
PUBLIC
Open Jobs
13
Pipeline & Clinical Trials
MuSK-CAART
MuSK Myasthenia GravisClinical Trials (1)
NCT05451212Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Phase 1CABA-201
Systemic SclerosisClinical Trials (1)
NCT06328777RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Phase 1/2CABA-201
Systemic Lupus ErythematosusClinical Trials (1)
NCT06121297RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Phase 1/2DSG3-CAART
Pemphigus VulgarisClinical Trials (1)
NCT04422912A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT06359041RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT07006805RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis
Phase 1/2CABA-201 following preconditioning with fludarabine and cyclophosphamide
Idiopathic Inflammatory MyopathyClinical Trials (1)
NCT06154252RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Phase 2/3Open Jobs (13)
Vice President and Head of Information Technology
Philadelphia, PA (Hybrid)
Information Technology2w ago
Vice President, Market Access, Commercial
Philadelphia, PA (Hybrid)
Commercial2w ago
Vice President, Biostatistics
Philadelphia, PA (Hybrid or Remote in Northeast preferred) (Hybrid)
Biostatistics2w ago
Sr. Director, Clinical and Regulatory Writing
Remote
Clinical, Medical and Regulatory2w ago
Directory, Regulatory
Philadelphia, PA or Remote (Hybrid)
Regulatory Affairs2w ago
$100K - $500K/yr
Talent Acquisition Specialist
Philadelphia, PA (Hybrid)
Human Resources2w ago
$60K - $100K/yr
GMP QC Specialist, CMC
Philadelphia, PA (Hybrid)
Quality Assurance2w ago
Sr. In-House Clinical Research Associate
Remote or Philadelphia, PA (Hybrid)
Clinical Operations2w ago
Audit Director, Quality & Compliance
Philadelphia, PA, Hybrid (Hybrid)
Quality & Compliance2w ago
$80K - $100K/yr
Sr. Medical Director, Clinical Development
Philadelphia, PA (Hybrid)
Clinical Development2w ago
Vice President, Regulatory Affairs
Remote
Regulatory Affairs2w ago
Senior Director, New Product Planning
Philadelphia, PA, Hybrid (Hybrid)
Product Planning2w ago
Supply Chain Associate
Philadelphia, PA (Hybrid)
Supply Chain2w ago
Interview Prep Quick Facts
Founded: 2018
Portfolio: 7 clinical trials
Top TAs: Neurology, Immunology
SEC Filings: 2 available
Open Roles: 13 active jobs